PeriRx offcially launches SaliMark OSCC, a molecular DNA test for the early detection of oral squamous cell carcinoma. Development of this simple-to-use, painless, and noninvasive test was based on NIH-funded research with initial discovery and pre-validation work conducted by Dr. David Wong of the University of California at Los Angeles. More than a decade of National Institute of Dental and Craniofacial Research and NIH-supported research make SaliMark OSCC the world's most scienti cally validated molecular DNA biomarker test for oral squamous cell carcinoma. The test is indicated for use when a visual oral examination (via naked eye or fluorescent device) detects a suspicious lesion or oral mucosal abnormality.
QUESTIONS & ANSWERS